Chembio Diagnostics Inc (CEMI.OQ)
CEMI.OQ on NASDAQ Stock Exchange Capital Market
6.93USD
15 Feb 2019
6.93USD
15 Feb 2019
Change (% chg)
$-0.04 (-0.57%)
$-0.04 (-0.57%)
Prev Close
$6.97
$6.97
Open
$7.00
$7.00
Day's High
$7.00
$7.00
Day's Low
$6.90
$6.90
Volume
4,995
4,995
Avg. Vol
18,229
18,229
52-wk High
$11.55
$11.55
52-wk Low
$4.87
$4.87
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 9.38 | -0.163 |
| Jun '18 | 8.72 | -0.122 | |
| Mar '18 | 7.72 | -0.049 | |
| FY 2017 | Dec '17 | 5.99 | -0.162 |
| Sep '17 | 7.59 | -0.047 | |
| Jun '17 | 4.11 | -0.177 | |
| Mar '17 | 6.33 | -0.132 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 4 | 9.41 | 9.90 | 9.01 | -- |
| Quarter Ending Jun-19 | 4 | 9.84 | 10.55 | 9.30 | -- |
| Year Ending Dec-19 | 4 | 40.39 | 42.53 | 39.00 | 44.41 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 4 | -0.12 | -0.09 | -0.14 | -- |
| Quarter Ending Jun-19 | 4 | -0.10 | -0.07 | -0.13 | -- |
| Year Ending Dec-19 | 4 | -0.36 | -0.29 | -0.45 | 0.07 |
| LT Growth Rate (%) | 1 | 25.00 | 25.00 | 25.00 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 30.48 | 33.70 | |
| P/E High - Last 5 Yrs. | 60.44 | 44.98 | 49.87 | |
| P/E Low - Last 5 Yrs. | 43.00 | 23.63 | 24.25 | |
| Beta | 1.19 | 0.90 | 0.90 | |
| Price to Sales (TTM) | 4.21 | 4.12 | 6.29 | |
| Price to Book (MRQ) | 5.03 | 5.10 | 5.26 | |
| Price to Tangible Book (MRQ) | 6.34 | 5.85 | 6.77 | |
| Price to Cash Flow (TTM) | -- | 24.01 | 24.98 | |
| % Owned Institutions | 31.32 | 0.90 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.49 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 1.51 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 4.15 | 4.85 | |
| Payout Ratio(TTM) | -- | 43.91 | 41.03 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 25.97 | 4.31 | 12.75 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -12.91 | 4.07 | 5.84 | |
| Sales - 5 Yr. Growth Rate | -1.62 | 10.91 | 11.23 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 79.54 | 44.94 | 47.15 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 29.28 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 10.31 | 10.85 | |
| Capital Spending - 5 Yr. Growth Rate | -30.40 | 15.88 | 15.20 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 2.37 | 2.15 | 2.25 |
| Current Ratio (MRQ) | 3.66 | 2.97 | 3.08 |
| LT Debt to Equity (MRQ) | 0.00 | 8.84 | 11.38 |
| Total Debt to Equity (MRQ) | 0.00 | 12.89 | 16.12 |
| Interest Coverage (TTM) | -- | 33.79 | 29.47 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 47.30 | 53.68 | 53.81 | |
| Gross Margin - 5 Yr. Avg. | 42.30 | 51.67 | 52.18 | |
| EBITD Margin (TTM) | -39.01 | -- | -- | |
| EBITD - 5 Yr. Avg | -4.67 | 17.96 | 12.86 | |
| Operating Margin (TTM) | -46.24 | 14.31 | 6.20 | |
| Operating Margin - 5 Yr. Avg. | -8.18 | 14.24 | 8.31 | |
| Pre-Tax Margin (TTM) | -46.01 | 14.85 | 7.16 | |
| Pre-Tax Margin - 5 Yr. Avg. | -8.15 | 14.68 | 8.61 | |
| Net Profit Margin (TTM) | -46.01 | 11.08 | 3.29 | |
| Net Profit Margin - 5 Yr. Avg. | -12.33 | 11.02 | 4.89 | |
| Effective Tax Rate (TTM) | -- | 23.02 | 22.91 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 23.16 | 23.38 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 140,773 | 957,645,487 | 842,397,297 | |
| Net Income/Employee (TTM) | -64,768 | 113,564,537 | 99,842,671 | |
| Receivable Turnover (TTM) | 3.99 | 5.71 | 5.71 | |
| Inventory Turnover (TTM) | 2.29 | 2.61 | 3.47 | |
| Asset Turnover (TTM) | 1.14 | 0.97 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -52.56 | 11.52 | 11.06 | |
| Return on Assets - 5 Yr. Avg. | -14.58 | 12.92 | 12.20 | |
| Return on Investment (TTM) | -68.16 | 14.95 | 14.45 | |
| Return on Investment - 5 Yr. Avg. | -17.83 | 16.84 | 15.87 | |
| Return on Equity (TTM) | -69.09 | 16.27 | 15.96 | |
| Return on Equity - 5 Yr. Avg. | -17.86 | 17.77 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -26.33 | -15.44 | -1.62 |
| EPS (TTM) % | -404.58 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Chembio Diagnostics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 5.00 | 1.38 | 64 | 22 |
| 13 Week | -0.79 | -5.62 | 51 | 39 |
| 26 Week | 15.60 | 6.81 | 76 | 33 |
| 52 Week | -13.10 | -26.35 | 34 | 9 |
| YTD | -7.35 | -18.64 | 33 | 26 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 43.16% |
| # of Holders: | 51 |
| Total Shares Held: | 7,417,437 |
| 3 Mo. Net Change: | 425,167 |
| # New Positions: | 17 |
| # Closed Positions: | 8 |
| # Increased Positions: | 37 |
| # Reduced Positions: | 14 |
| # Net Buyers: | 23 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.